Table of Contents  
RETRACTION
Year : 2022  |  Volume : 24  |  Issue : 6  |  Page : 684

Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression


1 Department of Pathology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China Department of Pathology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China Collaborative Innovation Center of Clinical Immunology Between Soochow University and Sihong People's Hospital, Sihong 223900, China Department of Pathology, Sihong People's Hospital, Sihong 223900, China Laboratory Animal Research Center, Soochow University School of Medicine, Suzhou 215123, China Department of Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China Suzhou Key Laboratory of Tumor Microenvironment and Pathology, Soochow University, Suzhou 215006, China

Date of Submission15-Sep-2022
Date of Acceptance25-Sep-2022
Date of Web Publication14-Oct-2022

Correspondence Address:
Shou-Li Wang
Department of Pathology, School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123; Suzhou Key Laboratory of Tumor Microenvironment and Pathology, Soochow University, Suzhou 215006
China
Yong-Sheng Zhang
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aja202285

Rights and Permissions

How to cite this article:
Hu YM, Lou XL, Liu BZ, Sun L, Wan S, Wu L, Zhao X, Zhou Q, Sun MM, Tao K, Zhang YS, Wang SL. Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression. Asian J Androl 2022;24:684

How to cite this URL:
Hu YM, Lou XL, Liu BZ, Sun L, Wan S, Wu L, Zhao X, Zhou Q, Sun MM, Tao K, Zhang YS, Wang SL. Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression. Asian J Androl [serial online] 2022 [cited 2022 Nov 29];24:684. Available from: https://www.ajandrology.com/text.asp?2022/24/6/684/358625

Yue-Mei Hu, Xiao-Li Lou
These authors contributed equally to this work.


Retraction to: Asian Journal of Andrology 2021; 23 (2): 188–96. Doi: 10.4103/aja.aja_60_20.

We are retracting this article due to certain errors in two figures in the article “TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression” which has been published. An image layout error occurred while processing [Figure 3]e, and some of the images in [Figure 3]f, [Figure 4]d, and [Figure 4]e have errors due to incorrect image grouping. We carried out a detailed investigation and rechecked the original data of these figures. Unfortunately, the original pathological data have not been properly archived; thus, we are unable to investigate this issue.

Considering that these errors may mislead readers, we think the most responsible action is to retract it. All authors agree to retract this article and deeply apologize for any confusion it may have caused.




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article

 Article Access Statistics
    Viewed534    
    Printed48    
    Emailed0    
    PDF Downloaded45    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]